Johnson & Johnson (JNJ) Stock Price | Stock Quote Nyse

Add to a list

To use this feature you must be a member

Log inSign up

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 10:07:33 2024-03-12 am EDT			5-day change	1st Jan Change
161.5 ^USD	+0.18%		+1.03%	+3.11%

12:40pm		CF
Mar. 11		DJ

Days Hours Minutes Seconds -40% on all our subscriptions* Exceptional extension! Enjoy this offer * See conditions on site

Financials (USD)

Sales 2024 *	88.28B	Sales 2025 *	90.69B	Capitalization	388B
Net income 2024 *	20.94B	Net income 2025 *	22.33B	EV / Sales 2024 *	4.24x
Net cash position 2024 *	14.08B	Net cash position 2025 *	27.24B	EV / Sales 2025 *	3.98x
P/E ratio 2024 *	18.1x	P/E ratio 2025 *	17x	Employees	131,900
Yield 2024 *	3.05%	Yield 2025 *	3.2%	Free-Float	77.04%

More Fundamentals * Assessed data

Duration

Period

Style

Dynamic Chart

Latest transcript on Johnson & Johnson

Mar. 04

More transcripts

	Jan. 24	MT
	Jan. 24	MT
The market awaits the BCE meeting and earnings reports	Jan. 23
The start of a new bull market?	Jan. 22
	Jan. 09	MT

More recommendations

Fiduciaries Beware: Employer Health Plan Under Fire For Alleged Prescription Drug Mismanagement	06:14am	AQ
	Mar. 11	BU
Change Healthcare network interruption patient and provider support	Mar. 11	AQ
	Mar. 07	BU
Alvotech Announces More Settlements And Expected Launch Dates Regarding Biosimilar To STELARA (Ustekinumab), AVT04	Mar. 05	AQ

More press releases

Compañías que se deben tener muy en cuenta por técnico este martes en Wall Street	09:57am
J&J : sollicite la FDA pour Tremfya dans la colite ulcéreuse	07:40am
J&J : nouvelles données dans le psoriasis en plaques	Mar. 11
J&J : finalise l'acquisition d'Ambrx Biopharma pour 2 Mds$	Mar. 07
Jeff, Bernard y Elon en un pañuelo	Mar. 05

More news

Quotes and Performance

1 day	+0.15%
1 week	+0.90%
Current month	+0.02%
1 month	+2.25%
3 months	+4.09%
6 months	-1.33%
Current year	+2.98%

More quotes

Highs and lows

1 week

158.24

162.38

1 month

154.84

162.57

Current year

154.84

163.58

1 year

144.95

175.97

3 years

144.95

186.69

5 years

109.16

186.69

10 years

81.79

186.69

More quotes

Managers	Title	Age	Since
Joaquin Duato CEO	Chief Executive Officer	61	88-12-31
Joseph Wolk DFI	Director of Finance/CFO	57	97-12-31
James Swanson CTO	Chief Tech/Sci/R&D Officer	58	19-11-04

Members of the board	Title	Age	Since
Marillyn Hewson BRD	Director/Board Member	71	19-04-24
D. Davis BRD	Director/Board Member	72	14-06-18
Anne Mulcahy BRD	Director/Board Member	70	09-10-21

More insiders

Name	Weight	AuM	1st Jan change	Investor Rating
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD	14.01%	227 M€	+7.49%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	12.91%	18 M€	+5.16%	-

Quotes

Date	Price	Change	Volume
24-03-12	161.7	+0.28%	889 453
24-03-11	161.2	+1.07%	4,620,826
24-03-08	159.5	+0.41%	5,283,951
24-03-07	158.9	-0.29%	5,188,726
24-03-06	159.3	-0.39%	5,773,683

Delayed Quote Nyse, March 12, 2024 at 09:44 am EDT

More quotes

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).

Sector

Pharmaceuticals

Calendar

01:00pm - Leerink Partners Global Biopharma Conference

Related indices

Dow Jones Industrial ,

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

More Strategies

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

161.2USD

Average target price

174.2USD

Spread / Average Target

+8.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
	+2.98%	388B
ELI LILLY AND COMPANY	+26.90%	661B
NOVO NORDISK A/S	+29.16%	585B
ABBVIE INC.	+16.67%	317B
	+12.09%	311B
ROCHE HOLDING AG	-0.12%	221B
ASTRAZENECA PLC	-1.19%	208B
NOVARTIS AG	+3.28%	207B
PFIZER, INC.	-3.16%	160B
SANOFI	-1.38%	121B

Other Pharmaceuticals

Stock
Equities
Stock Johnson & Johnson - Nyse

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities. SIGN UP NOW

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '4832');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });

Johnson & Johnson (JNJ) Stock Price | Stock Quote Nyse - MarketScreener (2024)

JNJ

US4781601046

Financials (USD)